From Ebola to Zika, SARS-CoV-2 to HIV, and H1N1 Swine Flu to RSV virus, globalization has fueled a fundamental change in the level of risk posed to society by dangerous pathogens.
Governments, corporations, NGOs, and individuals, rely more than ever on diagnostics to manage and respond to pathogenic risk.
Rugged design, 24/7 operation, 800 tests/hr, 10,000,000 tests & 10 year calibration and maintenance-free lifecycle
Specialized test kits, consultancy, and support, with insight services for best practice design, implementation, and monitoring to fit your needs
Out of the lab and into the field. Test at schools, airports, nursing homes, pharmacies, clinics, and other non-sterile environments. Any lateral flow assay from any manufacturer can be read with results in 3 seconds
Ultra low TCO for equitable use by all and for all in the field, hospitals, pop-up clinics, disaster areas, and emergencies, with minimal training required, while supporting locally produced on-demand test-kits and manufacturers anywhere
Quantitative results can include symptoms, vital signs, and calibrated values comparative to expensive, time consuming, and human error prone laboratory assays like PCR and ELISA
We’re meeting this challenge with our decentralized diagnostic solutions.
Universal and connected innovation to decentralize diagnostics.
The most efficient, sensitive, affordable, and environmentally friendly test kits with a multiplex capacity of up to 7 test lines per test. In addition to assaya’s LEIQA test kits, any test from any vendor can be analyzed with the assaya system
The world’s most versatile diagnostic testing hardware, built for the variable conditions of decentralized models and proven in the most demanding environments
Enterprise cloud systems capable of delivering tailored end-to-end solutions for any diagnostic testing model
Global repository of historical and real-time diagnostic testing data, customizable through integration with 3rd party data pools
Specialized consultancy, support, and insights services for best practice design, implementation, monitoring and continuous improvement
The iaX is designed to read and interpret all traditional test kits for any disease, pathogen, or biological/chemical marker with high efficiency and accuracy, regardless of the manufacturer. This versatility makes it an important tool for disease surveillance and outbreak response, as well as for routine diagnostic testing in healthcare settings around the world.
The iaX is also compatible with assaya’s Low Environmental Impact Quantitative Assay (LEIQA) test kits that allow for mass-scale RAPID testing of antigens, post-natural or artificial infection antibodies, and chemical/biological markers in humans, animals and nature, using recyclable medical-grade consumables and cost effective test strips
We are adding new tests and on-boarding new manufacturers and test kits every week. Contact us to add your test.
for mass-scale RAPID testing of antigen, post natural or artificial infection antibodies, and chemical/biological markers in humans, animals and nature, using any manufacturer’s Test Kit
Connected devices for instant results, live global support & new TestKits on-boarding
Results available instantly after reading in our free Assaya eXpress Progressive Web App (PWA) through the assayaDX API and into your own data bases, hospital management systems, for government or NGO Reporting, or in 3rd party Apps
In addition to standard export functions, our platform offers advanced real-time API updates that can be accessed using any programming language for all testing data.
This feature allows for seamless development of custom data models, visualizations, and integrations with other applications, providing scalable solutions.
With this flexible API, you can easily process and manipulate data to gain insights to drive successful solutions.
“Our goal is to make reliable and affordable rapid testing available to all, supported by accurate machine reading to overcome the issues of human error and lengthy wait times for results.”
Assaya Founder and Chief Science Officer